Retrospective analysis of 1539 nasopharyngeal carcinoma cases: chemotherapy should not be excluded for non-Asian patients with T1-2N1M0 stage

Retrospective analysis of 1539 nasopharyngeal carcinoma cases: chemotherapy should not be excluded for non-Asian patients with T1-2N1M0 stage

BackgroundMany results suggested that chemotherapy cannot provide survival benefit for stage II nasopharyngeal carcinoma. It remained unclear whether the efficacy of chemotherapy differed in non-Asian populations.ObjectiveIt was designed to analyze the effect of chemotherapy for Asian and non-Asian...

Full description

Saved in:
Bibliographic Details
Main Authors: Xin-Yu Li, Chang-Ying Zhong, Hui-Xian Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Oncology
Subjects:
nasopharyngeal carcinoma
chemotherapy
Asian
stage II
proportional hazard model
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1529136/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items